Bangladesh former Prime Minister Begum Khaleda Zia is set to travel abroad for medical treatment Bangladesh Nationalist Party BNP leaders confirmed on Mond ...

The 79-year-old former prime minister, who has been battling multiple health complications, including liver cirrhosis, heart ...

The therapeutic candidate is under development for the treatment of liver fibrosis and KRAS-driven liver cancer. It is an antisense RNAi oligonucleotide delivered through lipid-nanoparticles and is ...

BNP Chairperson Khaleda Zia will travel to London on Tuesday (7 January) night for advanced medical treatment, party Secretary General Mirza Fakhrul Islam Alamgir formally announced today (5 January).

With an estimated two billion people affected worldwide, fatty liver disease is a silent epidemic that often goes unnoticed until it’s too late. Learn the crucial early warning signs that could help ...

While there is ongoing research to develop better tools like biochemical markers to differentiate fibrosis stage in MASH patients, the only standard currently used in MASH clinical studies involves ...

Sequana Medical NV has announced the US FDA approval of its Alfapump system for treating recurrent or refractory ascites due to liver cirrhosis. This approval marks Alfapump as the first active ...

Biomarker staging of liver fibrosis in hepatitis C was cost effective, but so was initiating treatment without testing.